Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer.
about
Clinical and molecular features of young-onset colorectal cancerCancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screeningChallenges of deciphering gastric cancer heterogeneityCancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screeningHereditary Syndromes Manifesting as Endometrial Carcinoma: How Can Pathological Features Aid Risk Assessment?Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science reviewA Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.Suspected Lynch syndrome associated MSH6 variants: A functional assay to determine their pathogenicityRectal Cancer Diagnosed after Cesarean Section in Which High Microsatellite Instability Indicated the Presence of Lynch Syndrome.Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers.When is Genomic Testing Cost-Effective? Testing for Lynch Syndrome in Patients with Newly-Diagnosed Colorectal Cancer and Their Relatives.Genomics in Public Health: Perspective from the Office of Public Health Genomics at the Centers for Disease Control and Prevention (CDC)ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromesPreferences for genetic testing for colorectal cancer within a population-based screening program: a discrete choice experimentFactors Associated With the Performance of Extended Colonic Resection vs. Segmental Resection in Early-Onset Colorectal Cancer: A Population-Based StudyHereditary cancer syndromes: utilizing DNA repair deficiency as therapeutic targetLong-Term Outcome and Prognostic Factors of Sporadic Colorectal Cancer in Young Patients: A Large Institutional-Based Retrospective StudySuccessful implementation of Lynch syndrome screening in a safety net institution.How does genetic risk information for Lynch syndrome translate to risk management behaviours?Hereditary cancer syndromes in Latino populations: genetic characterization and surveillance guidelines.Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines.A comparison between Lynch syndrome and sporadic colorectal cancer survivors' satisfaction with their healthcare providersPractical opportunities to improve early detection and prevention of colorectal cancer (CRC) in members of high-risk families.Lynch syndrome: five unanswered questions.Lynch syndrome in the 21st century: clinical perspectives.Inherited predisposition to colorectal cancer: towards a more complete picture.Universal Screening of Colorectal Cancers for Lynch Syndrome: Challenges and Opportunities.Recognition of Lynch Syndrome Amongst Newly Diagnosed Colorectal Cancers at St. Paul's Hospital.Expending Role of Microsatellite Instability in Diagnosis and Treatment of Colorectal Cancers.Lynch Syndrome Limbo: Patient Understanding of Variants of Uncertain Significance.Advances in Biomarkers: Going Beyond the Carcinoembryonic Antigen.Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.Approach to Lynch Syndrome for the Gastroenterologist.Survival Outcome and Risk of Metachronous Colorectal Cancer After Surgery in Lynch Syndrome.Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database.Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database.Population-Based Lynch Syndrome Screening by Microsatellite Instability in Patients ≤50: Prevalence, Testing Determinants, and Result Availability Prior to Colon Surgery.Is there a role for prophylactic colectomy in Lynch syndrome patients with inflammatory bowel disease?Tumor testing to identify lynch syndrome in two Australian colorectal cancer cohorts.Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database
P2860
Q26768431-F341B163-0718-40ED-85B2-2FB038EC428EQ26770123-69FE2378-C3CC-4F96-88B7-0D9EE14C9EE7Q26784448-E7FA4B27-5AFD-4D9D-9D12-B633234B8168Q27001043-B64AA398-8C5E-4FC0-970C-A761BA4C44F8Q28085485-8FAE349C-9967-48BA-AA94-5B8E54137431Q30249867-E9F371D0-1DF6-4F7E-830A-8F78DBD2154DQ30252766-D2C4E1DF-661D-4B46-8ACF-F35D952AC66AQ33769290-02BC6E98-1505-44C9-88D3-A0531D1460D0Q35630565-D7E1E00E-33B2-4422-A5B3-8C4E343CC2F2Q36030785-6E4FC09F-966B-4ED5-8028-6E2D256C1396Q36157315-EB4B0415-3AD5-431E-B818-FB3F66C0E987Q36337518-3EC72748-F346-4773-8209-8E9F84B10F4FQ36416282-CACEC9B9-C1D3-48F2-93A6-48D3EBF8A84FQ36585023-A08EEC4E-7F8B-42F2-B670-94D289E722BFQ36864722-6F272C64-AFEC-49F4-935D-E176B6FD76EDQ36990060-B5F5388C-91C1-4CFE-BA8E-8D998332F4F9Q36993526-67B6F573-4274-4A3A-8A0C-EE3DFCD84C90Q37124128-42131943-7C7E-483F-BAC0-8250F6581609Q37566105-2A16FB8A-28A7-465E-9744-D150DA311932Q37597246-7B8C21EA-E2CC-4E93-B583-5B5343A6E27DQ37659105-D3659EC5-9DCA-401C-B5CF-4ED515D1EB33Q37693398-CE47215A-C96C-438C-86A2-6027454EE583Q38362344-E3F58507-CC44-42D0-8F28-8D65FCA0D744Q38367449-E740C498-57E9-4034-9428-263C58AB021EQ38557159-9BF97649-AA17-443E-B732-088BA66FEB45Q38571639-8680F0C3-A6CE-4E0E-B61A-CF6E38FABB6EQ38646561-1805748D-EF24-497A-9EDB-15939CC62958Q38656191-62E27685-713A-467C-B971-91ADD686C43DQ38683093-04D21F18-B60A-4DAB-979C-103B0C96A72AQ38765255-25BD0822-A0C9-411C-B4DF-850B54A48C47Q38943220-0ED9B065-6FBE-4B6B-8FB7-D953E8DE78EDQ38979257-BA605164-BC91-4649-956C-893B2B41D6B3Q39042915-597F7FA7-EF6A-45E0-9932-295913D31B58Q39264060-9C83FD09-3C19-4CAD-9370-CCAB9086D508Q40103447-C878B368-A380-437E-BA2D-EEFA4BECA1A8Q40221041-34BF1841-2D86-40F5-8007-FA83987EA4EBQ40250643-E7D25264-26D5-49C9-9471-E1B06ADFA2FFQ40494096-187F2024-11C7-48CC-90E7-4C6B4EAE7AEFQ40713486-C236EEED-0BE5-45D7-8B23-7FEB42811936Q40719336-4474CD47-0984-4E66-A2FE-1237E161A423
P2860
Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Guidelines on genetic evaluati ...... sk Force on colorectal cancer.
@en
Guidelines on genetic evaluati ...... sk Force on colorectal cancer.
@nl
type
label
Guidelines on genetic evaluati ...... sk Force on colorectal cancer.
@en
Guidelines on genetic evaluati ...... sk Force on colorectal cancer.
@nl
prefLabel
Guidelines on genetic evaluati ...... sk Force on colorectal cancer.
@en
Guidelines on genetic evaluati ...... sk Force on colorectal cancer.
@nl
P2093
P2860
P356
P1476
Guidelines on genetic evaluati ...... sk Force on colorectal cancer.
@en
P2093
C Richard Boland
Carol A Burke
David A Johnson
David A Lieberman
Douglas J Robertson
Francis M Giardiello
James M Church
Jennifer E Axilbund
John I Allen
Randall W Burt
P2860
P304
P356
10.1038/AJG.2014.186
P407
P577
2014-07-22T00:00:00Z